Details
ISBN/EAN: 978-3-330-65212-5
Einband: kartoniertes Buch
Weitere Details
Auflage:
1. Auflage 2017
1. Auflage 2017
Erschienen am:
03.06.2017
03.06.2017
Sprache:
English
English
Umfang:
216 S.
216 S.
Format (T/L/B):
1.4 x 22 x 15 cm
1.4 x 22 x 15 cm
Hersteller:
OmniScriptum SRL
info@omniscriptum.com
Str. Armeneasca 28/1, office 1
MD 2012 Chisinau
OmniScriptum SRL
info@omniscriptum.com
Str. Armeneasca 28/1, office 1
MD 2012 Chisinau
Weitere Details
arrow_forward_ios
Insilico study of Some Anticonvulsant Compounds
89,90 €
inkl. MwSt.
Lieferbar innerhalb 1 - 2 Wochen
Beschreibung
This book focuses on the quantitative structure-activity relationship (QSAR) and molecular docking studies of some anticonvulsant compounds. QSAR as a major factor in drug design, are mathematical equations relating chemical structure to their biological activity and it is also used to understand the structural features controlling the activities of neurotransmitters. While molecular docking is a computational technique used to predict conformation and binding affinity of intermolecular complexes based on the three-dimensional structures of an individual molecule. The modeled anticonvulsant compounds have shown that the binding affinity generated was found to be better than the commercially sold anti-epilepsy drug, vigabatrin and will be used to inhibit/deactivate the activities of gamma amino butyric acid aminotransferase (GABAAT), an enzyme that causes epilepsy.
Über Usman Abdulfatai, Adamu Uzairu, Sani Uba
ABOUT THE AUTHOR: Usman Abdulfatai is a research scholar in the Department of Chemistry, Ahmadu Bello University, Zaria-Nigeria. He received B.sc. degree in chemistry in 2011, Post graduate diploma in education (PGDE), in 2012 and M.sc. degree in physical chemistry in 2017. His research interest focuses on in-silico studies.